Combined fibrinolysis using reduced‐dose alteplase plus abciximab with immediate rescue angioplasty versus primary angioplasty with adjunct use of abciximab for the treatment of acute myocardial infarction: Asia‐Pacific Acute Myocardial Infarction Trial (APAMIT) pilot study